HeavenlyRx acquiert une participation majoritaire dans PureKana (en anglais)

On December 27, 2019, HeavenlyRx Ltd., a subsidiary of SOL Global Investments Corp., acquired a majority share of one of the largest top ranked CBD companies, PureKana, LLC. Under the agreement, HeavenlyRx acquired a majority ownership stake from PureKana’s founding members.

HeavenlyRx holds controlling ownership interests in various industry-leading assets in the hemp/CBD and THC-free cannabinoid wellness space, with a focus on hemp cultivation, processing and the manufacturing of a diverse range of traditional CBD products including oils, tinctures, balms, and vape-ready products.

PureKana is a rapidly growing brand, marketing CBD products fully derived from organic hemp to a large consumer base that leans toward a young and active demographic.

Gowling WLG was Canadian counsel to HeavenlyRx in this transaction with a team that included Peter Simeon, Josh Almario and Amanda Stevens.